From: The composition of lung microbiome in lung cancer: a systematic review and meta-analysis
Study | Population | Accession number | 16S region | Sequencing platform | CCN | Cases | Controls | Age (y/o) |
---|---|---|---|---|---|---|---|---|
Study 1 Apopa et al. [23] | AF & EU | PRJNA472758 | 27 F & 519R | Illumina MiSeq | 14 | 9 | 5 | 50–80 |
Study 2 Nejman et al. [47] | IL | PRJNA624822 | * | * | 476 | 245 | 231 | NA |
Study 3 Yu et al. [24] | IT 1 | PRJNA303190 | V3–V4 | Illumina MiSeq | 257 | 50 | 207 | 40–80 |
Study 4 - | IT 2 | PRJNA327258 | NA | Illumina MiSeq | 53 | 27 | 26 | 40–80 |
Study 5 Kovaleva et al. [48] | RU | PRJNA647170 | V3–V4 | Illumina MiSeq | 49 | 25 | 24 | 62\(\pm 10\) |
Total | Â | Â | Â | Â | 849 | 356 | 493 | Â |